Trial Profile
Prevention of Depression in Patients Being Treated for Head and Neck Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Sep 2023
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Acronyms PROTECT
- 22 May 2013 Results presented at the 166th Annual Meeting of the American Psychiatric Association.
- 22 Mar 2013 Primary endpoint 'Quick-Inventory-of-Depressive-Symptomology-Self-Report' has been met according to results presented at the 166th Annual Meeting of the American Psychiatric Association.
- 08 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.